Latest filing published 03 Sept 2026 for Mirum Pharmaceuticals, Inc., €57k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Jolanda Howe on record concern Mirum Pharmaceuticals, Inc. We count 22 filings; the first trade dates from 30 June 2023 and the latest from 2 September 2026.
The open-market record consists of 5 sales worth €3.9M, with no purchase. The rest of the record consists of 17 option exercises. So far in 2026, the count stands at no purchases and 3 sales.
On 3 September 2026 came the latest disclosure, an open-market sale for €57k in Mirum Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations